Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord MSCs for radiation-induced pulmonary fibrosis
NCT02277145Phase 1Completed
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human umbilical cord mesenchymal stem cells in pulmonary fibrosis (PF). Primary endpoint: Composite indicators including CT density histograms, self-evaluation and TGF-β1 content at 6 months. Started Oct 2014; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT02277145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277145.